(Q48228259)

9 February 2018

title

Diagnosis of hepatic encephalopathy: will in vivo proton MRS play a role? (English)

1 reference

9 February 2018

main subject

hepatic encephalopathy

1 reference

3

Hayes PC

1 reference

9 February 2018

Steven Olde Damink

series ordinal

2

object named as

Olde Damink SW

1 reference

9 February 2018

author name string

Jalan R

series ordinal

1

1 reference

9 February 2018

Wardlaw JM

series ordinal

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 February 2018

number of pages

3

1 reference

inferred from page(s)

published in

Hepatology

1 reference

9 February 2018

volume

29

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

1605-1607

1 reference

9 February 2018

Hepatic encephalopathy and ascites

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

The electroencephalograph in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290537

7 January 2021

Identifiers

DOI

10.1002/HEP.510290537

1 reference

9 February 2018

1 reference

9 February 2018